HZ

Hancheng ZHANG

HC Hangzhou Innogate Pharma Co.: 3 patents #1 of 3Top 35%
Overall (2022): #80,389 of 548,613Top 15%
3
Patents 2022

Issued Patents 2022

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11352353 Heterocyclic compound serving as FGFR4 inhibitor Shifeng Liu, Xiangyang YE 2022-06-07
11266640 Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor Xiangyang YE 2022-03-08
11225492 Heterocycles useful as anti-cancer agents Shifeng Liu 2022-01-18